LeBlanc H, Chauvet D, Lombrail P, Robert J J
Diabetes Care. 1986 Mar-Apr;9(2):124-8. doi: 10.2337/diacare.9.2.124.
Blood glucose levels were compared in eight type I diabetic subjects who were given closed-loop infusions of insulin by intraperitoneal (i.p.) and intravenous (i.v.) routes, in a cross-over randomized study. After a test meal, plasma glucose peaks were significantly higher with i.p. than with i.v. infusion (174 +/- 22 versus 129 +/- 29 mg/dl) and marked hypoglycemia occurred after 180 min in five of eight subjects. These observations appear to be the consequence of a 60-min lag in insulin rise with i.p. administration. Because of this difference in plasma glucose rise, twice as much insulin was administered i.p. than with i.v. Plasma insulin rose to similar values in both cases. Therefore, with present closed-loop systems, i.p. insulin infusion does not lead to better control of glucose levels than i.v. infusion and does not prevent hyperinsulinism. Adjustments of the artificial B-cell algorithms and the injection of a bolus dose must be tested so that the potential advantages of the i.p. route may be achieved.
在一项交叉随机研究中,对8名I型糖尿病受试者进行了比较,这些受试者通过腹腔内(i.p.)和静脉内(i.v.)途径接受胰岛素闭环输注。试验餐后,腹腔内输注时的血浆葡萄糖峰值显著高于静脉内输注(174±22对129±29mg/dl),8名受试者中有5名在180分钟后出现明显低血糖。这些观察结果似乎是腹腔内给药时胰岛素升高延迟60分钟的结果。由于血浆葡萄糖升高存在这种差异,腹腔内给药的胰岛素剂量是静脉内给药的两倍。两种情况下血浆胰岛素升高至相似值。因此,对于目前的闭环系统,腹腔内胰岛素输注在控制血糖水平方面并不比静脉内输注更好,也不能预防高胰岛素血症。必须测试人工B细胞算法的调整和大剂量注射,以便实现腹腔内途径的潜在优势。